Dexcom Inc. buy Wells Fargo & Company
Start price
13.02.26
/
50%
€59.65
Target price
13.02.27
€71.61
Performance (%)
-1.46%
Price
18.03.26
€58.78
Summary
This prediction is currently active. With a performance of -1.46%, the BUY prediction by Wells_Fargo___Compan is trending in the wrong direction. This prediction currently runs until 13.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Dexcom Inc. | 2.601% | 2.601% |
| iShares Core DAX® | -2.116% | -8.178% |
| iShares Nasdaq 100 | -1.132% | 0.908% |
| iShares Nikkei 225® | -0.658% | -6.257% |
| iShares S&P 500 | -1.261% | -1.001% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Dexcom Inc. diskutieren
DexCom (NASDAQ:DXCM) had its price target lowered by analysts at Wells Fargo & Company from $93.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for DXCM provided by MarketBeat